Cargando…
MYC inhibitors in multiple myeloma
The importance of MYC function in cancer was discovered in the late 1970s when the sequence of the avian retrovirus that causes myelocytic leukemia was identified. Since then, over 40 years of unceasing research have highlighted the significance of this protein in malignant transformation, especiall...
Autores principales: | Martínez-Martín, Sandra, Soucek, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992455/ https://www.ncbi.nlm.nih.gov/pubmed/35582389 http://dx.doi.org/10.20517/cdr.2021.55 |
Ejemplares similares
-
Targeting MYC-driven lymphoma: lessons learned and future directions
por: Martínez-Martín, Sandra, et al.
Publicado: (2023) -
The long journey to bring a Myc inhibitor to the clinic
por: Whitfield, Jonathan R., et al.
Publicado: (2021) -
Tumor microenvironment: becoming sick of Myc
por: Whitfield, Jonathan R., et al.
Publicado: (2011) -
Anaplastic multiple myeloma with MYC rearrangement
por: Ichikawa, Satoshi, et al.
Publicado: (2021) -
MYC dysregulation in the progression of multiple myeloma
por: Misund, K, et al.
Publicado: (2019)